Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
6
×
clinical trials
life sciences
national blog main
biotech
boston blog main
boston top stories
fda
national top stories
new york blog main
allergan
eli lilly
merck
migraine
national
new york top stories
startups
venture capital
accelerator life science partners
access biotechnology
access industries
acorda therapeutics
adalimumab (humira)
aducanumab
aduro biotech
affordable care act
alez azar
alzheimer's disease
amgen
ampyra
anemia
antibiotics
apokyn
apomorphine
arch venture partners
atlas ventures
axial spondyloarthritis
bausch health
big pharma
biogen
What
new
6
×
fda
approved
drug
medicine
nod
treatment
treatments
according
acorda
adults
advance
allergan
anemia
approval
approves
based
benefit
bio
biogen’s
biopharmaceutical
blood
body
carry
cash
cells
class
companies
company
convo
cope
disc
disease
drop
drops
earlier
episodes
eye
failures
filing
Language
unset
Current search:
abbvie
×
new
×
@extremetech.com
2 years ago
FDA Approves New Eye Drops that Could Replace Glasses for Millions
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Disc Medicine Launches With $50M to Advance New Anemia Treatments
@xconomy.com
4 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@geekwire.com
5 years ago
Seattle startup Rodeo Therapeutics raises more cash for regenerative medicine treatments
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
